000 01219 a2200361 4500
005 20250517174602.0
264 0 _c20180206
008 201802s 0 0 eng d
022 _a0040-5957
024 7 _a10.1016/j.therap.2017.06.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRevol, Bruno
245 0 0 _aImmunoglobulins: Benefits and risks from the patient's point of view.
_h[electronic resource]
260 _bTherapie
_cDec 2017
300 _a683-684 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aFemale
650 0 4 _aHospitals, University
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xadministration & dosage
650 0 4 _aImmunoglobulins, Intravenous
_xadministration & dosage
650 0 4 _aInformed Consent
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPatient Education as Topic
_xmethods
650 0 4 _aSurveys and Questionnaires
700 1 _aBickert, Laura
700 1 _aSarrot-Reynauld, Françoise
700 1 _aAllenet, Benoit
773 0 _tTherapie
_gvol. 72
_gno. 6
_gp. 683-684
856 4 0 _uhttps://doi.org/10.1016/j.therap.2017.06.005
_zAvailable from publisher's website
999 _c27595854
_d27595854